Advanced Bovine Antibody (with Ultralong CDR3) Humanization Services

Background Service Platform Application Related Services FAQ Online Inquiry

Bovine (cow) antibodies represent a paradigm shift in antigen recognition, distinguished by an exceptionally long third complementarity-determining region of the heavy chain (CDRH3). This "ultralong CDR3," often exceeding 50 amino acids, forms a unique "knob-and-stalk" structure, enabling it to penetrate and bind to cryptic or recessed epitopes that are inaccessible to standard human or murine antibodies. Creative Biolabs stands at the forefront of antibody engineering, offering a world-class Bovine Antibody (with Ultralong CDR3) Humanization Service. We harness the unprecedented targeting capabilities of bovine antibodies and meticulously engineer them to minimize immunogenicity for clinical applications, transforming these remarkable molecules into potent therapeutic candidates.

Discuss Your Project Today

The Biology of Bovine Antibodies: Nature's Innovation in Antigen Binding

The bovine immune system has evolved a unique architectural solution for its antibody repertoire. Unlike the V(D)J recombination in humans and mice that primarily generates diversity in CDR3 length and sequence, cattle utilize a single VH gene segment and a limited number of DH segments. To compensate, they generate extraordinary diversity through somatic hypermutation and extreme junctional diversification, resulting in a significant portion of their antibodies possessing ultralong CDRH3 loops.

Key Structural Features of Bovine Antibodies

Ultralong CDR3: These loops can be up to 70 amino acids long, creating a distinct structural domain that projects far from the antibody framework.
Knob-and-Stalk Architecture: The ultralong CDR3 folds into a stable, disulfide-bonded β-ribbon "stalk" and a disulfide-bonded "knob" at its apex. The knob domain is hypervariable and serves as the primary antigen-binding interface.

Fig. 1 Development of bovine and human antibodies with ultra-long CDRs. (OA Literature) Fig. 1 Design principles for the development of bovine and human antibodies with ultra-long CDRs.¹

Unparalleled Advantages of Ultralong CDR3 Bovine Antibodies

The unique structure of bovine antibodies translates into significant therapeutic advantages:

Targeting Cryptic Epitopes: The extended knob domain can access recessed active sites on enzymes, ion channels, and G protein-coupled receptors (GPCRs), which are often considered "undruggable" by conventional antibodies.
High Affinity and Specificity: The extensive binding surface of the knob domain often results in exceptionally high-affinity interactions with the target antigen.
Novel Mechanisms of Action: By binding to previously inaccessible functional sites, these antibodies can modulate target activity in novel ways, such as allosteric inhibition or stabilization of specific protein conformations.
Potent Neutralization: This architecture is particularly effective at neutralizing viruses and toxins by blocking critical protein-protein interaction sites.

Creative Biolabs' Bovine Antibody Humanization Platform: A State-of-the-Art Humanization Strategy

To address these unique challenges, Creative Biolabs has developed the Bovine Antibody Humanization platform, a sophisticated, multi-pronged approach that combines advanced computational modeling with proven protein engineering techniques. Our platform ensures the highest probability of success in generating a safe, stable, and potent humanized bovine antibody.

Our Step-by-Step Humanization Process

Initial Analysis and 3D Modeling: We begin by sequencing the variable domains of the parent bovine antibody. Using this sequence, we generate a high-resolution, 3D homology model to meticulously map the critical interactions between the ultralong CDR3 and the supporting framework.
Intelligent Human Framework Selection: Our scientists utilize a proprietary human germline framework library. We select the human acceptor framework with the highest sequence homology and, more importantly, the structural compatibility to best support the bovine ultralong CDR3 conformation.
Structure-Guided CDR Grafting: We perform a precise graft of the bovine CDRs, including the entire ultralong CDRH3, onto the selected human framework. Our structural analysis identifies which bovine framework residues are essential for maintaining the CDR's structure and must be retained.
Strategic Back-Mutations: This is a critical step. Based on our 3D model, we judiciously introduce "back-mutations" (reverting specific human framework residues to their bovine counterparts) only where necessary to preserve the CDR conformation and binding affinity. This is done with extreme care to avoid reintroducing immunogenic epitopes.
In Silico Immunogenicity Prediction: Before synthesis, all humanized variants are run through advanced computational algorithms to predict potential T-cell epitopes. This allows us to de-immunize the sequence further, selecting candidates with the lowest possible immunogenicity risk score.
Expression and Purification: The top humanized antibody candidates are synthesized and expressed in a system of your choice (e.g., CHO, HEK293) and purified to the highest standards.
Comprehensive Biophysical Validation: We perform rigorous characterization to ensure the final humanized antibody meets and exceeds expectations.

Key Features and Advantages of Our Bovine Antibody Humanization Service

Feature	Advantage
Structure-Based Design	Our reliance on high-resolution 3D modeling minimizes trial-and-error, increasing the success rate and preserving native affinity and specificity.
Proprietary Framework Library	Access to a curated library of human frameworks allows us to find the optimal structural match for your unique ultralong CDR3.
Multi-Parameter Optimization	We simultaneously optimize for low immunogenicity, high affinity, high expression levels, and excellent biophysical stability.
Deep Expertise	Our team has decades of collective experience in antibody engineering and has overcome the specific challenges associated with non-traditional antibody formats.
Comprehensive Reporting	You receive a detailed report including all sequences, expression data, and full biophysical characterization results.
Flexible and Customizable	Our services are tailored to your specific project needs, from initial feasibility studies to full-scale development and manufacturing.

Applications for Humanized Bovine Antibodies

The unique targeting ability of humanized bovine antibodies opens up new therapeutic possibilities across numerous disease areas:

Oncology: Targeting cryptic sites on tumor-associated antigens or growth factor receptors.
Infectious Diseases: Potent neutralization of viruses (e.g., HIV, influenza) by blocking conserved, recessed epitopes.
Autoimmune Diseases: Modulating the activity of key cytokines or cell-surface receptors.
Ion Channel and GPCR Modulation: Developing highly specific modulators for these notoriously difficult membrane protein targets.

Explore Our Comprehensive Antibody Services

To support your entire antibody development pipeline, we offer a comprehensive suite of related services:

Leverage Creative Biolabs' deep expertise and state-of-the-art Bovine Antibody Humanization platform to develop next-generation biologics. Our dedicated team of scientists is ready to partner with you to overcome the most difficult antibody engineering challenges.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQs)

Q: How much sequence identity can be achieved with a human antibody?

A: Our Bovine Antibody Humanization platform typically achieves over 90-95% sequence identity with human germline frameworks in the variable regions, significantly reducing the risk of immunogenicity.

Q: Will the humanization process affect the antibody's affinity?

A: Our primary goal is affinity preservation. Our structure-guided approach, which includes careful framework selection and strategic back-mutations, is designed to retain the binding affinity of the parental bovine antibody. We validate this with rigorous biophysical testing.

Q: What materials do I need to provide to start a project?

A: Ideally, you would provide the amino acid or DNA sequence of the variable heavy (VH) and variable light (VL) domains of your bovine antibody. If you only have the hybridoma cell line, we can perform sequencing as an initial step.

Reference

Svilenov, Hristo L., et al. "Mechanistic principles of an ultra-long bovine CDR reveal strategies for antibody design." Nature Communications 12.1 (2021): 6737. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1038/s41467-021-27103-z

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.